Publications by authors named "Chuck Hague"

Claim this Profile
I
Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction.
Jenna Magat, Samantha Jones, Brian Baridon, Vishal Agrawal, Hio Wong, Chuck Hague

J Biol Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
Joseph C Chen, Amanda R Luu, Nathan Wise, Rolando De Angelis, Vishal Agrawal, Chuck Hague

J Biol Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular Uptake and Delivery of Myeloperoxidase to Lysosomes Promote Lipofuscin Degradation and Lysosomal Stress in Retinal Cells.
Gouri Yogalingam, Amanda R Lee, Donald S Mackenzie, Travis J Maures, Agnes Rafalko, Chuck Hague

J Biol Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB.
Shih-Hsin Kan, Mika Aoyagi-Scharber, Steven Q Le, Jon Vincelette, Kazuhiro Ohmi, Chuck M Hague

Proc Natl Acad Sci U S A· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Melita Dvorak-Ewell, Dan Wendt, Chuck Hague, Terri Christianson, Vish Koppaka

PLoS One· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis